{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:17:37Z","timestamp":1778221057080,"version":"3.51.4"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["DGAPA-PAPIIT IN204325"],"award-info":[{"award-number":["DGAPA-PAPIIT IN204325"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["clave 15758"],"award-info":[{"award-number":["clave 15758"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10337-y","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:28:21Z","timestamp":1778214501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circadian clock control of breast cancer hallmarks: molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"45","author":[{"given":"Luis Ricardo","family":"Hern\u00e1ndez-Barrientos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Aguilar-Arnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"10337_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74, 229\u2013263.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10337_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N., et al. (2019). Breast cancer. Nature Reviews\u00a0Disease Primers, 5, 66.","journal-title":"Nature Reviews\u00a0Disease Primers"},{"key":"10337_CR3","doi-asserted-by":"crossref","unstructured":"Lukasiewicz S, et al. (2021). Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-An updated review. Cancers (Basel) 13, 4287","DOI":"10.3390\/cancers13174287"},{"key":"10337_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli, G., Lam, M. T. Y., & Panda, S. (2019). Interplay between circadian clock and cancer: New frontiers for cancer treatment. Trends in Cancer, 5, 475\u2013494.","journal-title":"Trends in Cancer"},{"key":"10337_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0092-8674(00)80566-8","volume":"96","author":"JC Dunlap","year":"1999","unstructured":"Dunlap, J. C. (1999). Molecular bases for circadian clocks. Cell, 96, 271\u2013290.","journal-title":"Cell"},{"key":"10337_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1146\/annurev.ph.55.030193.000313","volume":"55","author":"CS Pittendrigh","year":"1993","unstructured":"Pittendrigh, C. S. (1993). Temporal organization: Reflections of a Darwinian clock-watcher. Annual Review of Physiology, 55, 16\u201354.","journal-title":"Annual Review of Physiology"},{"key":"10337_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0092-8674(02)01225-4","volume":"111","author":"U Schibler","year":"2002","unstructured":"Schibler, U., & Sassone-Corsi, P. (2002). A web of circadian pacemakers. Cell, 111, 919\u2013922.","journal-title":"Cell"},{"key":"10337_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0704-0","volume":"11","author":"F Rijo-Ferreira","year":"2019","unstructured":"Rijo-Ferreira, F., & Takahashi, J. S. (2019). Genomics of circadian rhythms in health and disease. Genome Medicine, 11, Article 82.","journal-title":"Genome Medicine"},{"key":"10337_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1751-1097.1997.tb03188.x","volume":"66","author":"T Roenneberg","year":"1997","unstructured":"Roenneberg, T., & Foster, R. G. (1997). Twilight times: Light and the circadian system. Photochemistry and Photobiology, 66, 549\u2013561.","journal-title":"Photochemistry and Photobiology"},{"key":"10337_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tins.2007.11.002","volume":"31","author":"MW Hankins","year":"2008","unstructured":"Hankins, M. W., Peirson, S. N., & Foster, R. G. (2008). Melanopsin: An exciting photopigment. Trends in Neurosciences, 31, 27\u201336.","journal-title":"Trends in Neurosciences"},{"key":"10337_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","volume":"19","author":"MH Hastings","year":"2018","unstructured":"Hastings, M. H., Maywood, E. S., & Brancaccio, M. (2018). Generation of circadian rhythms in the suprachiasmatic nucleus. Nature Reviews. Neuroscience, 19, 453\u2013469.","journal-title":"Nature Reviews. Neuroscience"},{"key":"10337_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature00965","volume":"418","author":"SM Reppert","year":"2002","unstructured":"Reppert, S. M., & Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nature, 418, 935\u2013941.","journal-title":"Nature"},{"key":"10337_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1126\/science.1195262","volume":"330","author":"ED Buhr","year":"2010","unstructured":"Buhr, E. D., Yoo, S. H., & Takahashi, J. S. (2010). Temperature as a universal resetting cue for mammalian circadian oscillators. Science, 330, 379\u2013385.","journal-title":"Science"},{"key":"10337_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","volume":"72","author":"C Dibner","year":"2010","unstructured":"Dibner, C., Schibler, U., & Albrecht, U. (2010). The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annual Review of Physiology, 72, 517\u2013549.","journal-title":"Annual Review of Physiology"},{"key":"10337_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1073\/pnas.95.1.340","volume":"95","author":"I Provencio","year":"1998","unstructured":"Provencio, I., Jiang, G., De Grip, W. J., Hayes, W. P., & Rollag, M. D. (1998). Melanopsin: An opsin in melanophores, brain, and eye. Proceedings of the National Academy of Sciences of the United States of America, 95, 340\u2013345.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/07420520701283693","volume":"24","author":"H Dardente","year":"2007","unstructured":"Dardente, H., & Cermakian, N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiology International, 24, 195\u2013213.","journal-title":"Chronobiology International"},{"key":"10337_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn3208","volume":"13","author":"AA Kondratova","year":"2012","unstructured":"Kondratova, A. A., & Kondratov, R. V. (2012). The circadian clock and pathology of the ageing brain. Nature Reviews Neuroscience, 13, 325\u2013335.","journal-title":"Nature Reviews Neuroscience"},{"key":"10337_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12576-018-0597-5","volume":"68","author":"S Honma","year":"2018","unstructured":"Honma, S. (2018). The mammalian circadian system: A hierarchical multi-oscillator structure for generating circadian rhythm. The Journal of Physiological Sciences, 68, 207\u2013219.","journal-title":"The Journal of Physiological Sciences"},{"key":"10337_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.288.5468.1013","volume":"288","author":"LP Shearman","year":"2000","unstructured":"Shearman, L. P., et al. (2000). Interacting molecular loops in the mammalian circadian clock. Science, 288, 1013\u20131019.","journal-title":"Science"},{"key":"10337_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0092-8674(00)80245-7","volume":"89","author":"DP King","year":"1997","unstructured":"King, D. P., et al. (1997). Positional cloning of the mouse circadian clock gene. Cell, 89, 641\u2013653.","journal-title":"Cell"},{"key":"10337_CR21","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1073\/pnas.95.10.5474","volume":"95","author":"JB Hogenesch","year":"1998","unstructured":"Hogenesch, J. B., Gu, Y. Z., Jain, S., & Bradfield, C. A. (1998). The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proceedings of the National Academy of Sciences of the United States of America, 95, 5474\u20135479.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/bbrc.1998.9275","volume":"250","author":"S Honma","year":"1998","unstructured":"Honma, S., et al. (1998). Circadian oscillation of BMAL1, a partner of a mammalian clock gene clock, in rat suprachiasmatic nucleus. Biochemical and Biophysical Research Communications, 250, 83\u201387.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10337_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1222804","volume":"337","author":"N Huang","year":"2012","unstructured":"Huang, N., et al. (2012). Crystal structure of the heterodimeric CLOCK: BMAL1 transcriptional activator complex. Science, 337, 189\u2013194.","journal-title":"Science"},{"key":"10337_CR24","doi-asserted-by":"publisher","first-page":"13871","DOI":"10.1021\/bi962209o","volume":"35","author":"DS Hsu","year":"1996","unstructured":"Hsu, D. S., et al. (1996). Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins. Biochemistry, 35, 13871\u201313877.","journal-title":"Biochemistry"},{"key":"10337_CR25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1126\/science.282.5393.1490","volume":"282","author":"RJ Thresher","year":"1998","unstructured":"Thresher, R. J., et al. (1998). Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. Science, 282, 1490\u20131494.","journal-title":"Science"},{"key":"10337_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/geno.1996.0539","volume":"37","author":"PJ van der Spek","year":"1996","unstructured":"van der Spek, P. J., et al. (1996). Cloning, tissue expression, and mapping of a human photolyase homolog with similarity to plant blue-light receptors. Genomics, 37, 177\u2013182.","journal-title":"Genomics"},{"key":"10337_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0092-8674(00)80366-9","volume":"90","author":"ZS Sun","year":"1997","unstructured":"Sun, Z. S., et al. (1997). RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell, 90, 1003\u20131011.","journal-title":"Cell"},{"key":"10337_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/39086","volume":"389","author":"H Tei","year":"1997","unstructured":"Tei, H., et al. (1997). Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature, 389, 512\u2013516.","journal-title":"Nature"},{"key":"10337_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0092-8674(00)80495-X","volume":"91","author":"U Albrecht","year":"1997","unstructured":"Albrecht, U., Sun, Z. S., Eichele, G., & Lee, C. C. (1997). A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell, 91, 1055\u20131064.","journal-title":"Cell"},{"key":"10337_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0896-6273(00)80417-1","volume":"19","author":"LP Shearman","year":"1997","unstructured":"Shearman, L. P., Zylka, M. J., Weaver, D. R., Kolakowski, L. F., Jr., & Reppert, S. M. (1997). Two period homologs: Circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron, 19, 1261\u20131269.","journal-title":"Neuron"},{"key":"10337_CR31","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1093\/emboj\/17.16.4753","volume":"17","author":"T Takumi","year":"1998","unstructured":"Takumi, T., et al. (1998). A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. The EMBO Journal, 17, 4753\u20134759.","journal-title":"The EMBO Journal"},{"key":"10337_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.3413487","volume":"241","author":"MR Ralph","year":"1988","unstructured":"Ralph, M. R., & Menaker, M. (1988). A mutation of the circadian system in golden hamsters. Science, 241, 1225\u20131227.","journal-title":"Science"},{"key":"10337_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0014-5793(00)01755-5","volume":"477","author":"A Takano","year":"2000","unstructured":"Takano, A., et al. (2000). Cloning and characterization of rat casein kinase 1epsilon. FEBS Letters, 477, 106\u2013112.","journal-title":"FEBS Letters"},{"key":"10337_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nrc1072","volume":"3","author":"L Fu","year":"2003","unstructured":"Fu, L., & Lee, C. C. (2003). The circadian clock: Pacemaker and tumour suppressor. Nature Reviews Cancer, 3, 350\u2013361.","journal-title":"Nature Reviews Cancer"},{"key":"10337_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03674","volume":"3","author":"SN Nangle","year":"2014","unstructured":"Nangle, S. N., et al. (2014). Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex. eLife, 3, Article e03674.","journal-title":"eLife"},{"key":"10337_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0677-2","volume":"11","author":"I Pacheco-Bernal","year":"2019","unstructured":"Pacheco-Bernal, I., Becerril-Perez, F., & Aguilar-Arnal, L. (2019). Circadian rhythms in the three-dimensional genome: Implications of chromatin interactions for cyclic transcription. Clinical Epigenetics, 11, Article 79.","journal-title":"Clinical Epigenetics"},{"key":"10337_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)00825-5","volume":"110","author":"N Preitner","year":"2002","unstructured":"Preitner, N., et al. (2002). The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell, 110, 251\u2013260.","journal-title":"Cell"},{"key":"10337_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrn1177","volume":"4","author":"MH Hastings","year":"2003","unstructured":"Hastings, M. H., Reddy, A. B., & Maywood, E. S. (2003). A clockwork web: Circadian timing in brain and periphery, in health and disease. Nature Reviews Neuroscience, 4, 649\u2013661.","journal-title":"Nature Reviews Neuroscience"},{"key":"10337_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fphys.2019.00682","volume":"10","author":"Y Xie","year":"2019","unstructured":"Xie, Y., et al. (2019). New insights into the circadian rhythm and its related diseases. Frontiers in Physiology, 10, 682.","journal-title":"Frontiers in Physiology"},{"key":"10337_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12927","volume":"48","author":"A Angelousi","year":"2018","unstructured":"Angelousi, A., et al. (2018). Clock genes alterations and endocrine disorders. European Journal of Clinical Investigation, 48, Article e12927.","journal-title":"European Journal of Clinical Investigation"},{"key":"10337_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41583-018-0088-y","volume":"20","author":"RW Logan","year":"2019","unstructured":"Logan, R. W., & McClung, C. A. (2019). Rhythms of life: Circadian disruption and brain disorders across the lifespan. Nature Reviews Neuroscience, 20, 49\u201365.","journal-title":"Nature Reviews Neuroscience"},{"key":"10337_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1017\/S0954422410000016","volume":"23","author":"LC Antunes","year":"2010","unstructured":"Antunes, L. C., Levandovski, R., Dantas, G., Caumo, W., & Hidalgo, M. P. (2010). Obesity and shift work: Chronobiological aspects. Nutrition Research Reviews, 23, 155\u2013168.","journal-title":"Nutrition Research Reviews"},{"key":"10337_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001141","volume":"8","author":"A Pan","year":"2011","unstructured":"Pan, A., Schernhammer, E. S., Sun, Q., & Hu, F. B. (2011). Rotating night shift work and risk of type 2 diabetes: Two prospective cohort studies in women. PLoS Medicine, 8, Article e1001141.","journal-title":"PLoS Medicine"},{"key":"10337_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071597","author":"E Maury","year":"2019","unstructured":"Maury, E. (2019). Off the clock: From circadian disruption to metabolic disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20071597","journal-title":"International Journal of Molecular Sciences"},{"key":"10337_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0743-z","volume":"18","author":"V Blakeman","year":"2016","unstructured":"Blakeman, V., Williams, J. L., Meng, Q. J., & Streuli, C. H. (2016). Circadian clocks and breast cancer. Breast Cancer Research, 18, Article 89.","journal-title":"Breast Cancer Research"},{"key":"10337_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tem.2019.05.001","volume":"30","author":"A Verlande","year":"2019","unstructured":"Verlande, A., & Masri, S. (2019). Circadian clocks and cancer: Timekeeping governs cellular metabolism. Trends in Endocrinology and Metabolism, 30, 445\u2013458.","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10337_CR47","doi-asserted-by":"publisher","DOI":"10.1289\/EHP1837","volume":"126","author":"A Garcia-Saenz","year":"2018","unstructured":"Garcia-Saenz, A., et al. (2018). Evaluating the association between artificial light-at-night exposure and breast and prostate cancer risk in Spain (MCC-Spain study). Environmental Health Perspectives, 126, Article 047011.","journal-title":"Environmental Health Perspectives"},{"key":"10337_CR48","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41416-020-01231-7","volume":"124","author":"RR Jones","year":"2021","unstructured":"Jones, R. R. (2021). Exposure to artificial light at night and risk of cancer: Where do we go from here? British Journal of Cancer, 124, 1467\u20131468.","journal-title":"British Journal of Cancer"},{"key":"10337_CR49","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s10552-010-9624-4","volume":"21","author":"I Kloog","year":"2010","unstructured":"Kloog, I., Stevens, R. G., Haim, A., & Portnov, B. A. (2010). Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes & Control, 21, 2059\u20132068.","journal-title":"Cancer Causes & Control"},{"key":"10337_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.23938\/ASSN.0307","volume":"41","author":"E Salamanca-Fernandez","year":"2018","unstructured":"Salamanca-Fernandez, E., et al. (2018). Night-shift work and breast and prostate cancer risk: Updating the evidence from epidemiological studies. Anales del Sistema Sanitario de Navarra, 41, 211\u2013226.","journal-title":"Anales del Sistema Sanitario de Navarra"},{"key":"10337_CR51","doi-asserted-by":"crossref","unstructured":"IARC Monographs Working Group. (2019). Carcinogenicity of night shift work. Lancet Oncology, 20, 1058\u20131059.","DOI":"10.1016\/S1470-2045(19)30383-3"},{"key":"10337_CR52","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1210\/jc.2010-2098","volume":"96","author":"JJ Gooley","year":"2011","unstructured":"Gooley, J. J., et al. (2011). Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. Journal of Clinical Endocrinology and Metabolism, 96, E463-472.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10337_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.ede.0000152525.21924.54","volume":"16","author":"RG Stevens","year":"2005","unstructured":"Stevens, R. G. (2005). Circadian disruption and breast cancer: From melatonin to clock genes. Epidemiology, 16, 254\u2013258.","journal-title":"Epidemiology"},{"key":"10337_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-079X.2004.00165.x","volume":"37","author":"RJ Reiter","year":"2004","unstructured":"Reiter, R. J. (2004). Mechanisms of cancer inhibition by melatonin. Journal of Pineal Research, 37, 213\u2013214.","journal-title":"Journal of Pineal Research"},{"key":"10337_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.smrv.2008.07.007","volume":"13","author":"DE Blask","year":"2009","unstructured":"Blask, D. E. (2009). Melatonin, sleep disturbance and cancer risk. Sleep Medicine Reviews, 13, 257\u2013264.","journal-title":"Sleep Medicine Reviews"},{"key":"10337_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00051295","volume":"7","author":"T Tynes","year":"1996","unstructured":"Tynes, T., Hannevik, M., Andersen, A., Vistnes, A. I., & Haldorsen, T. (1996). Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes & Control, 7, 197\u2013204.","journal-title":"Cancer Causes & Control"},{"key":"10337_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10654-018-0368-x","volume":"33","author":"E Cordina-Duverger","year":"2018","unstructured":"Cordina-Duverger, E., et al. (2018). Night shift work and breast cancer: A pooled analysis of population-based case-control studies with complete work history. European Journal of Epidemiology, 33, 369\u2013379.","journal-title":"European Journal of Epidemiology"},{"key":"10337_CR58","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/jnci\/93.20.1513","volume":"93","author":"J Hansen","year":"2001","unstructured":"Hansen, J. (2001). Light at night, shiftwork, and breast cancer risk. Journal of the National Cancer Institute, 93, 1513\u20131515.","journal-title":"Journal of the National Cancer Institute"},{"key":"10337_CR59","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/0748730415609727","volume":"30","author":"Y Hamaguchi","year":"2015","unstructured":"Hamaguchi, Y., Tahara, Y., Hitosugi, M., & Shibata, S. (2015). Impairment of circadian rhythms in peripheral clocks by constant light is partially reversed by scheduled feeding or exercise. Journal of Biological Rhythms, 30, 533\u2013542.","journal-title":"Journal of Biological Rhythms"},{"key":"10337_CR60","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1101\/gad.183500","volume":"14","author":"F Damiola","year":"2000","unstructured":"Damiola, F., et al. (2000). Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes & Development, 14, 2950\u20132961.","journal-title":"Genes & Development"},{"key":"10337_CR61","doi-asserted-by":"crossref","unstructured":"Healy, K. L., Morris, A. R. & Liu, A. C. (2021). Circadian synchrony: sleep, nutrition, and physical activity.\u00a0Frontiers in Network Physiology,\u00a01,\u00a0732243.","DOI":"10.3389\/fnetp.2021.732243"},{"key":"10337_CR62","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144, 646\u2013674.","journal-title":"Cell"},{"key":"10337_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188900","volume":"1878","author":"SM Ortega-Campos","year":"2023","unstructured":"Ortega-Campos, S. M., Verdugo-Sivianes, E. M., Amiama-Roig, A., Blanco, J. R., & Carnero, A. (2023). Interactions of circadian clock genes with the hallmarks of cancer. Biochimica et Biophysica Acta. Reviews on Cancer, 1878, Article 188900.","journal-title":"Biochimica et Biophysica Acta. Reviews on Cancer"},{"key":"10337_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1086271","volume":"302","author":"T Matsuo","year":"2003","unstructured":"Matsuo, T., et al. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science, 302, 255\u2013259.","journal-title":"Science"},{"key":"10337_CR65","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41467-020-20513-5","volume":"12","author":"AA Shafi","year":"2021","unstructured":"Shafi, A. A., et al. (2021). The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nature Communications, 12, 401.","journal-title":"Nature Communications"},{"key":"10337_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.celrep.2012.07.005","volume":"2","author":"LD Jensen","year":"2012","unstructured":"Jensen, L. D., et al. (2012). Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish. Cell Reports, 2, 231\u2013241.","journal-title":"Cell Reports"},{"key":"10337_CR67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1101\/sqb.2007.72.050","volume":"72","author":"RV Kondratov","year":"2007","unstructured":"Kondratov, R. V., & Antoch, M. P. (2007). The clock proteins, aging, and tumorigenesis. Cold Spring Harbor Symposia on Quantitative Biology, 72, 477\u2013482.","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10337_CR68","doi-asserted-by":"crossref","unstructured":"Joshi, H. & Press, M. F. (2018). Molecular oncology of breast cancer, In\u00a0K. I. Bland, E. M. Copeland, V. S. Klimberg, & W. J. Gradishar (Eds.),\u00a0The Breast.\u00a0(pp. 282\u2013307.e285), Elsevier.","DOI":"10.1016\/B978-0-323-35955-9.00022-2"},{"key":"10337_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M., & Maley, C. C. (2012). Clonal evolution in cancer. Nature, 481, 306\u2013313.","journal-title":"Nature"},{"key":"10337_CR70","first-page":"64","volume":"1866","author":"K Tanaka","year":"2016","unstructured":"Tanaka, K., & Hirota, T. (2016). Chromosomal instability: A common feature and a therapeutic target of cancer. Biochimica et Biophysica Acta, 1866, 64\u201375.","journal-title":"Biochimica et Biophysica Acta"},{"key":"10337_CR71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan, F., & Reis-Filho, J. S. (2022). Pathogenesis of triple-negative breast cancer. Annual Review of Pathology: Mechanisms of Disease, 17, 181\u2013204.","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10337_CR72","doi-asserted-by":"crossref","unstructured":"Gotoh, T., Vila-Caballer, M., Liu, J., Schiffhauer, S., & Finkielstein, C. V. (2015). Association of the circadian factor Period 2 to p53 influences p53\u2019s function in DNA-damage signaling. Molecular Biology of the Cell, 26, 359\u2013372.","DOI":"10.1091\/mbc.E14-05-0994"},{"key":"10337_CR73","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1091\/mbc.e14-05-0993","volume":"25","author":"T Gotoh","year":"2014","unstructured":"Gotoh, T., et al. (2014). The circadian factor period 2 modulates p53 stability and transcriptional activity in unstressed cells. Molecular Biology of the Cell, 25, 3081\u20133093.","journal-title":"Molecular Biology of the Cell"},{"key":"10337_CR74","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1093\/nar\/gku094","volume":"42","author":"TH Kang","year":"2014","unstructured":"Kang, T. H., & Leem, S. H. (2014). Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome 1. Nucleic Acids Research, 42, 4427\u20134434.","journal-title":"Nucleic Acids Research"},{"key":"10337_CR75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/15384101.2018.1558638","volume":"18","author":"E Farshadi","year":"2019","unstructured":"Farshadi, E., et al. (2019). The positive circadian regulators CLOCK and BMAL1 control G2\/M cell cycle transition through Cyclin B1. Cell Cycle, 18, 16\u201333.","journal-title":"Cell Cycle"},{"key":"10337_CR76","doi-asserted-by":"publisher","first-page":"11807","DOI":"10.1038\/ncomms11807","volume":"7","author":"A Shostak","year":"2016","unstructured":"Shostak, A., et al. (2016). MYC\/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation. Nature Communications, 7, 11807.","journal-title":"Nature Communications"},{"key":"10337_CR77","doi-asserted-by":"crossref","unstructured":"Fu, L., Pelicano, H., Liu, J., Huang, P., & Lee, C. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell, 111, 41\u201350.","DOI":"10.1016\/S0092-8674(02)00961-3"},{"key":"10337_CR78","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2011.02.038","volume":"585","author":"S Reischl","year":"2011","unstructured":"Reischl, S., & Kramer, A. (2011). Kinases and phosphatases in the mammalian circadian clock. FEBS Letters, 585, 1393\u20131399.","journal-title":"FEBS Letters"},{"key":"10337_CR79","doi-asserted-by":"publisher","first-page":"318ra202","DOI":"10.1126\/scitranslmed.aac8773","volume":"7","author":"LH Rosenberg","year":"2015","unstructured":"Rosenberg, L. H., et al. (2015). Therapeutic targeting of casein kinase 1\u03b4 in breast cancer. Science Translational Medicine, 7, 318ra202-318ra202.","journal-title":"Science Translational Medicine"},{"key":"10337_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022). Cell cycle control in cancer. Nature Reviews. Molecular Cell Biology, 23, 74\u201388.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10337_CR81","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","volume":"6","author":"A Shahbandi","year":"2020","unstructured":"Shahbandi, A., Nguyen, H. D., & Jackson, J. G. (2020). TP53 mutations and outcomes in breast cancer: Reading beyond the headlines. Trends in Cancer, 6, 98\u2013110.","journal-title":"Trends in Cancer"},{"key":"10337_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01510-6","volume":"24","author":"AC Watt","year":"2022","unstructured":"Watt, A. C., & Goel, S. (2022). Cellular mechanisms underlying response and resistance to CDK4\/6 inhibitors in the treatment of hormone receptor-positive breast cancer. Breast Cancer Research, 24, Article 17.","journal-title":"Breast Cancer Research"},{"key":"10337_CR83","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews. Genetics, 18, 164\u2013179.","journal-title":"Nature Reviews. Genetics"},{"key":"10337_CR84","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/07853890.2014.892296","volume":"46","author":"M Sotak","year":"2014","unstructured":"Sotak, M., Sumova, A., & Pacha, J. (2014). Cross-talk between the circadian clock and the cell cycle in cancer. Annals of Medicine, 46, 221\u2013232.","journal-title":"Annals of Medicine"},{"key":"10337_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2024.100030","volume":"77","author":"A Glaviano","year":"2025","unstructured":"Glaviano, A., et al. (2025). Cell cycle dysregulation in cancer. Pharmacological Reviews, 77, Article 100030.","journal-title":"Pharmacological Reviews"},{"key":"10337_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051073","author":"N Verma","year":"2019","unstructured":"Verma, N., et al. (2019). DNA damage stress: Cui prodest? International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20051073","journal-title":"International Journal of Molecular Sciences"},{"key":"10337_CR87","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.jmb.2020.04.003","volume":"432","author":"E Farshadi","year":"2020","unstructured":"Farshadi, E., van der Horst, G. T. J., & Chaves, I. (2020). Molecular links between the circadian clock and the cell cycle. Journal of Molecular Biology, 432, 3515\u20133524.","journal-title":"Journal of Molecular Biology"},{"key":"10337_CR88","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3399","volume":"12","author":"NJ Curtin","year":"2012","unstructured":"Curtin, N. J. (2012). DNA repair dysregulation from cancer driver to therapeutic target. Nature Reviews. Cancer, 12, 801\u2013817.","journal-title":"Nature Reviews. Cancer"},{"key":"10337_CR89","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.febslet.2010.03.017","volume":"584","author":"A Sancar","year":"2010","unstructured":"Sancar, A., et al. (2010). Circadian clock control of the cellular response to DNA damage. FEBS Letters, 584, 2618\u20132625.","journal-title":"FEBS Letters"},{"key":"10337_CR90","doi-asserted-by":"crossref","unstructured":"Liu, Z., et al. (2020). Circadian regulation of c-MYC in mice.\u00a0Proceedings of the National Academy of Sciences of the United States of America, 117, 21609\u201321617.","DOI":"10.1073\/pnas.2011225117"},{"key":"10337_CR91","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cmet.2015.09.003","volume":"22","author":"BJ Altman","year":"2015","unstructured":"Altman, B. J., et al. (2015). MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metabolism, 22, 1009\u20131019.","journal-title":"Cell Metabolism"},{"key":"10337_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000228","volume":"17","author":"Y Lee","year":"2019","unstructured":"Lee, Y., et al. (2019). G1\/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLoS Biology, 17, Article e3000228.","journal-title":"PLoS Biology"},{"key":"10337_CR93","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1074\/jbc.M705576200","volume":"283","author":"A Grechez-Cassiau","year":"2008","unstructured":"Grechez-Cassiau, A., Rayet, B., Guillaumond, F., Teboul, M., & Delaunay, F. (2008). The circadian clock component BMAL1 is a critical regulator of p21WAF1\/CIP1 expression and hepatocyte proliferation. Journal of Biological Chemistry, 283, 4535\u20134542.","journal-title":"Journal of Biological Chemistry"},{"key":"10337_CR94","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1073\/pnas.1213317110","volume":"110","author":"E Kowalska","year":"2013","unstructured":"Kowalska, E., et al. (2013). NONO couples the circadian clock to the cell cycle. Proceedings of the National Academy of Sciences of the United States of America, 110, 1592\u20131599.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR95","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.molcel.2006.03.038","volume":"22","author":"S Gery","year":"2006","unstructured":"Gery, S., et al. (2006). The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Molecular Cell, 22, 375\u2013382.","journal-title":"Molecular Cell"},{"key":"10337_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004798","volume":"4","author":"J Mullenders","year":"2009","unstructured":"Mullenders, J., Fabius, A. W., Madiredjo, M., Bernards, R., & Beijersbergen, R. L. (2009). A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS ONE, 4, Article e4798.","journal-title":"PLoS ONE"},{"key":"10337_CR97","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.canlet.2015.12.002","volume":"371","author":"W Jiang","year":"2016","unstructured":"Jiang, W., et al. (2016). The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Cancer Letters, 371, 314\u2013325.","journal-title":"Cancer Letters"},{"key":"10337_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","volume":"7","author":"F Fagiani","year":"2022","unstructured":"Fagiani, F., et al. (2022). Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduction and Targeted Therapy, 7, 41.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10337_CR99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cell.2007.04.015","volume":"129","author":"T Hunt","year":"2007","unstructured":"Hunt, T., & Sassone-Corsi, P. (2007). Riding tandem: Circadian clocks and the cell cycle. Cell, 129, 461\u2013464.","journal-title":"Cell"},{"key":"10337_CR100","doi-asserted-by":"publisher","first-page":"12036","DOI":"10.1073\/pnas.1108125108","volume":"108","author":"JH Lee","year":"2011","unstructured":"Lee, J. H., & Sancar, A. (2011). Regulation of apoptosis by the circadian clock through NF-kappaB signaling. Proceedings of the National Academy of Sciences of the United States of America, 108, 12036\u201312041.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR101","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/ERC-20-0475","volume":"28","author":"EM Stephenson","year":"2021","unstructured":"Stephenson, E. M., Usselmann, L. E. J., Tergaonkar, V., Virshup, D. M., & Dallmann, R. (2021). Cancer clocks in tumourigenesis: The p53 pathway and beyond. Endocrine-Related Cancer, 28, R95\u2013R110.","journal-title":"Endocrine-Related Cancer"},{"key":"10337_CR102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101416118","volume":"118","author":"AB Chan","year":"2021","unstructured":"Chan, A. B., et al. (2021). CRY2 missense mutations suppress P53 and enhance cell growth. Proceedings of the National Academy of Sciences, 118, Article e2101416118.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10337_CR103","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1073\/pnas.0813028106","volume":"106","author":"N Ozturk","year":"2009","unstructured":"Ozturk, N., Lee, J. H., Gaddameedhi, S., & Sancar, A. (2009). Loss of Cryptochrome reduces cancer risk in p53 mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 106, 2841\u20132846.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR104","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/1940-6207.CAPR-09-0127","volume":"3","author":"AE Hoffman","year":"2010","unstructured":"Hoffman, A. E., et al. (2010). The core circadian gene cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prevention Research, 3, 539\u2013548.","journal-title":"Cancer Prevention Research"},{"key":"10337_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-110","volume":"10","author":"AE Hoffman","year":"2010","unstructured":"Hoffman, A. E., et al. (2010). Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways. BMC Cancer, 10, Article 110.","journal-title":"BMC Cancer"},{"key":"10337_CR106","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbrc.2015.09.103","volume":"467","author":"SK Chun","year":"2015","unstructured":"Chun, S. K., et al. (2015). A synthetic Cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells. Biochemical and Biophysical Research Communications, 467, 441\u2013446.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10337_CR107","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cels.2018.01.013","volume":"6","author":"Y Ye","year":"2018","unstructured":"Ye, Y., et al. (2018). The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy. Cell Systems, 6, 314-328 e312.","journal-title":"Cell Systems"},{"key":"10337_CR108","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1038\/sj.onc.1210585","volume":"26","author":"S Gery","year":"2007","unstructured":"Gery, S., Virk, R. K., Chumakov, K., Yu, A., & Koeffler, H. P. (2007). The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene, 26, 7916\u20137920.","journal-title":"Oncogene"},{"key":"10337_CR109","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/onc.2012.518","volume":"32","author":"S Li","year":"2013","unstructured":"Li, S., et al. (2013). CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-\u03b1. Oncogene, 32, 4883\u20134891.","journal-title":"Oncogene"},{"key":"10337_CR110","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcimb.2020.00096","volume":"10","author":"R Orozco-Solis","year":"2020","unstructured":"Orozco-Solis, R., & Aguilar-Arnal, L. (2020). Circadian regulation of immunity through epigenetic mechanisms. Frontiers in Cellular and Infection Microbiology, 10, 96.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10337_CR111","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.celrep.2015.04.058","volume":"11","author":"S Hemmers","year":"2015","unstructured":"Hemmers, S., & Rudensky, A. Y. (2015). The cell-intrinsic circadian clock is dispensable for lymphocyte differentiation and function. Cell Reports, 11, 1339\u20131349.","journal-title":"Cell Reports"},{"key":"10337_CR112","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/imm.12157","volume":"140","author":"A Baumann","year":"2013","unstructured":"Baumann, A., et al. (2013). The circadian clock is functional in eosinophils and mast cells. Immunology, 140, 465\u2013474.","journal-title":"Immunology"},{"key":"10337_CR113","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbi.2011.10.001","volume":"26","author":"AC Silver","year":"2012","unstructured":"Silver, A. C., Arjona, A., Hughes, M. E., Nitabach, M. N., & Fikrig, E. (2012). Circadian expression of clock genes in mouse macrophages, dendritic cells, and B cells. Brain, Behavior, and Immunity, 26, 407\u2013413.","journal-title":"Brain, Behavior, and Immunity"},{"key":"10337_CR114","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41577-018-0008-4","volume":"18","author":"C Scheiermann","year":"2018","unstructured":"Scheiermann, C., Gibbs, J., Ince, L., & Loudon, A. (2018). Clocking in to immunity. Nature Reviews. Immunology, 18, 423\u2013437.","journal-title":"Nature Reviews. Immunology"},{"key":"10337_CR115","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-020-16890-6","volume":"11","author":"E Hadadi","year":"2020","unstructured":"Hadadi, E., et al. (2020). Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nature Communications, 11, 3193.","journal-title":"Nature Communications"},{"key":"10337_CR116","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.bbrc.2020.05.012","volume":"527","author":"M Amir","year":"2020","unstructured":"Amir, M., Campbell, S., Kamenecka, T. M., & Solt, L. A. (2020). Pharmacological modulation and genetic deletion of REV-ERBalpha and REV-ERBbeta regulates dendritic cell development. Biochemical and Biophysical Research Communications, 527, 1000\u20131007.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10337_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo, B., Fu, S., Zhang, J., Liu, B., & Li, Z. (2016). Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Scientific Reports, 6, Article 36107.","journal-title":"Scientific Reports"},{"key":"10337_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24752","volume":"10","author":"J Huang","year":"2024","unstructured":"Huang, J., & Li, W. (2024). Molecular crosstalk between circadian clock and NLRP3 inflammasome signaling in Parkinson\u2019s disease. Heliyon, 10, Article e24752.","journal-title":"Heliyon"},{"key":"10337_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh, S., & Zeiser, R. (2020). NLRP3 inflammasome activation in cancer: A double-edged sword. Frontiers in Immunology, 11, Article 1444.","journal-title":"Frontiers in Immunology"},{"key":"10337_CR120","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.aah4966","volume":"354","author":"K Man","year":"2016","unstructured":"Man, K., Loudon, A., & Chawla, A. (2016). Immunity around the clock. Science (New York, N.Y.), 354, 999\u20131003.","journal-title":"Science (New York, N.Y.)"},{"key":"10337_CR121","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","volume":"10","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y., Guo, Z., Wu, M., Chen, F., & Chen, L. (2024). Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell Death & Disease Discovery, 10, 199.","journal-title":"Cell Death & Disease Discovery"},{"key":"10337_CR122","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCO.0000000000000153","volume":"27","author":"S Masri","year":"2015","unstructured":"Masri, S., Kinouchi, K., & Sassone-Corsi, P. (2015). Circadian clocks, epigenetics, and cancer. Current Opinion in Oncology, 27, 50\u201356.","journal-title":"Current Opinion in Oncology"},{"key":"10337_CR123","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12, 31\u201346.","journal-title":"Cancer Discovery"},{"key":"10337_CR124","doi-asserted-by":"crossref","unstructured":"Mahendran, G., et al. (2024). Unlocking the epigenetic code: New insights into triple-negative breast cancer. Frontiers in Oncology,\u00a014,\u00a01499950.","DOI":"10.3389\/fonc.2024.1499950"},{"key":"10337_CR125","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10528-019-09938-w","volume":"58","author":"F Hernandez-Rosas","year":"2020","unstructured":"Hernandez-Rosas, F., Lopez-Rosas, C. A., & Saavedra-Velez, M. V. (2020). Disruption of the molecular circadian clock and cancer: An epigenetic link. Biochemical Genetics, 58, 189\u2013209.","journal-title":"Biochemical Genetics"},{"key":"10337_CR126","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/ijc.32655","volume":"146","author":"K Prajzendanc","year":"2020","unstructured":"Prajzendanc, K., et al. (2020). BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer. International Journal of Cancer, 146, 1293\u20131298.","journal-title":"International Journal of Cancer"},{"key":"10337_CR127","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones, P. A., & Baylin, S. B. (2007). The epigenomics of cancer. Cell, 128, 683\u2013692.","journal-title":"Cell"},{"key":"10337_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155174","volume":"254","author":"KS Prabhu","year":"2024","unstructured":"Prabhu, K. S., et al. (2024). Beyond genetics: Exploring the role of epigenetic alterations in breast cancer. Pathology, Research and Practice, 254, Article 155174.","journal-title":"Pathology, Research and Practice"},{"key":"10337_CR129","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13148-016-0282-6","volume":"8","author":"Q Tang","year":"2016","unstructured":"Tang, Q., Cheng, J., Cao, X., Surowy, H., & Burwinkel, B. (2016). Blood-based DNA methylation as biomarker for breast cancer: A systematic review. Clinical Epigenetics, 8, 115.","journal-title":"Clinical Epigenetics"},{"key":"10337_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119360","author":"L Ma","year":"2023","unstructured":"Ma, L., et al. (2023). The mechanism of DNA methylation and miRNA in breast cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms24119360","journal-title":"International Journal of Molecular Sciences"},{"key":"10337_CR131","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-17-2082","volume":"78","author":"CR Good","year":"2018","unstructured":"Good, C. R., et al. (2018). TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Research, 78, 4126\u20134137.","journal-title":"Cancer Research"},{"key":"10337_CR132","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-008-0133-z","volume":"117","author":"X Yang","year":"2009","unstructured":"Yang, X., et al. (2009). Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Research and Treatment, 117, 423\u2013431.","journal-title":"Breast Cancer Research and Treatment"},{"key":"10337_CR133","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1158\/0008-5472.CAN-09-3798","volume":"70","author":"AE Hoffman","year":"2010","unstructured":"Hoffman, A. E., et al. (2010). CLOCK in breast tumorigenesis: Genetic, epigenetic, and transcriptional profiling analyses. Cancer Research, 70, 1459\u20131468.","journal-title":"Cancer Research"},{"key":"10337_CR134","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/carcin\/bgi075","volume":"26","author":"ST Chen","year":"2005","unstructured":"Chen, S. T., et al. (2005). Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis, 26, 1241\u20131246.","journal-title":"Carcinogenesis"},{"key":"10337_CR135","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00428-009-0761-7","volume":"454","author":"SJ Kuo","year":"2009","unstructured":"Kuo, S. J., et al. (2009). Disturbance of circadian gene expression in breast cancer. Virchows Archiv, 454, 467\u2013474.","journal-title":"Virchows Archiv"},{"key":"10337_CR136","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/07420528.2019.1617732","volume":"36","author":"M Lesicka","year":"2019","unstructured":"Lesicka, M., et al. (2019). A different methylation profile of circadian genes promoter in breast cancer patients according to clinicopathological features. Chronobiology International, 36, 1103\u20131114.","journal-title":"Chronobiology International"},{"key":"10337_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118101","volume":"10","author":"L Xia","year":"2015","unstructured":"Xia, L., et al. (2015). Daily variation in global and local DNA methylation in mouse livers. PLoS ONE, 10, Article e0118101.","journal-title":"PLoS ONE"},{"key":"10337_CR138","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1101\/gad.927301","volume":"15","author":"Y Zhang","year":"2001","unstructured":"Zhang, Y., & Reinberg, D. (2001). Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes & Development, 15, 2343\u20132360.","journal-title":"Genes & Development"},{"key":"10337_CR139","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1073\/pnas.1214168110","volume":"110","author":"UK Valekunja","year":"2013","unstructured":"Valekunja, U. K., et al. (2013). Histone methyltransferase MLL3 contributes to genome-scale circadian transcription. Proceedings of the National Academy of Sciences of the United States of America, 110, 1554\u20131559.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR140","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nsmb.2990","volume":"22","author":"L Aguilar-Arnal","year":"2015","unstructured":"Aguilar-Arnal, L., Katada, S., Orozco-Solis, R., & Sassone-Corsi, P. (2015). NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1. Nature Structural & Molecular Biology, 22, 312\u2013318.","journal-title":"Nature Structural & Molecular Biology"},{"key":"10337_CR141","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1126\/science.1206022","volume":"333","author":"L DiTacchio","year":"2011","unstructured":"DiTacchio, L., et al. (2011). Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Science, 333, 1881\u20131885.","journal-title":"Science"},{"key":"10337_CR142","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1101\/sqb.2007.72.049","volume":"72","author":"B Grimaldi","year":"2007","unstructured":"Grimaldi, B., et al. (2007). Chromatin remodeling and circadian control: Master regulator CLOCK is an enzyme. Cold Spring Harbor Symposia on Quantitative Biology, 72, 105\u2013112.","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10337_CR143","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2006.03.033","volume":"125","author":"M Doi","year":"2006","unstructured":"Doi, M., Hirayama, J., & Sassone-Corsi, P. (2006). Circadian regulator CLOCK is a histone acetyltransferase. Cell, 125, 497\u2013508.","journal-title":"Cell"},{"key":"10337_CR144","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2013.120","volume":"33","author":"M Roth","year":"2014","unstructured":"Roth, M., & Chen, W. Y. (2014). Sorting out functions of sirtuins in cancer. Oncogene, 33, 1609\u20131620.","journal-title":"Oncogene"},{"key":"10337_CR145","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2008.07.002","volume":"134","author":"Y Nakahata","year":"2008","unstructured":"Nakahata, Y., et al. (2008). The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell, 134, 329\u2013340.","journal-title":"Cell"},{"key":"10337_CR146","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc5629","author":"CM Greco","year":"2020","unstructured":"Greco, C. M., et al. (2020). S-adenosyl-l-homocysteine hydrolase links methionine metabolism to the circadian clock and chromatin remodeling. Science Advances. https:\/\/doi.org\/10.1126\/sciadv.abc5629","journal-title":"Science Advances"},{"key":"10337_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194940","author":"HY Loh","year":"2019","unstructured":"Loh, H. Y., et al. (2019). The regulatory role of microRNAs in breast cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20194940","journal-title":"International Journal of Molecular Sciences"},{"key":"10337_CR148","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/clockssleep2030022","volume":"2","author":"C Kinoshita","year":"2020","unstructured":"Kinoshita, C., Okamoto, Y., Aoyama, K., & Nakaki, T. (2020). MicroRNA: A key player for the interplay of circadian rhythm abnormalities, sleep disorders and neurodegenerative diseases. Clocks & Sleep, 2, 282\u2013307.","journal-title":"Clocks & Sleep"},{"key":"10337_CR149","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12935-025-03649-6","volume":"25","author":"X Li","year":"2025","unstructured":"Li, X., Hu, Y., & Aslanbeigi, F. (2025). Genetic and epigenetic alterations in night shift nurses with breast cancer: A narrative review. Cancer Cell International, 25, 20.","journal-title":"Cancer Cell International"},{"key":"10337_CR150","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri, M. A., Ansari, S. A., Alqahtani, M. H., & Shay, J. W. (2016). Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Medicine, 8, 69.","journal-title":"Genome Medicine"},{"key":"10337_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2016.00083","volume":"7","author":"KA Lewis","year":"2016","unstructured":"Lewis, K. A., & Tollefsbol, T. O. (2016). Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Frontiers in Genetics, 7, Article 83.","journal-title":"Frontiers in Genetics"},{"key":"10337_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00250-8","volume":"7","author":"EM da Silva","year":"2021","unstructured":"da Silva, E. M., et al. (2021). TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. Npj Breast Cancer, 7, Article 43.","journal-title":"Npj Breast Cancer"},{"key":"10337_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1218987","volume":"14","author":"F Lin","year":"2023","unstructured":"Lin, F., et al. (2023). Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer. Frontiers in Immunology, 14, Article 1218987.","journal-title":"Frontiers in Immunology"},{"key":"10337_CR154","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbrc.2014.07.138","volume":"451","author":"WD Chen","year":"2014","unstructured":"Chen, W. D., et al. (2014). The circadian rhythm controls telomeres and telomerase activity. Biochemical and Biophysical Research Communications, 451, 408\u2013414.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10337_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589929","volume":"11","author":"M Dratwa","year":"2020","unstructured":"Dratwa, M., Wysoczanska, B., Lacina, P., Kubik, T., & Bogunia-Kubik, K. (2020). TERT-regulation and roles in cancer formation. Frontiers in Immunology, 11, Article 589929.","journal-title":"Frontiers in Immunology"},{"key":"10337_CR156","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V., & Locasale, J. W. (2016). The Warburg effect: How does it benefit cancer cells? Trends in Biochemical Sciences, 41, 211\u2013218.","journal-title":"Trends in Biochemical Sciences"},{"key":"10337_CR157","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","volume":"24","author":"S Masri","year":"2018","unstructured":"Masri, S., & Sassone-Corsi, P. (2018). The emerging link between cancer, metabolism, and circadian rhythms. Nature Medicine, 24, 1795\u20131803.","journal-title":"Nature Medicine"},{"key":"10337_CR158","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N., & Thompson, C. B. (2016). The emerging hallmarks of cancer metabolism. Cell Metabolism, 23, 27\u201347.","journal-title":"Cell Metabolism"},{"key":"10337_CR159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cmet.2016.09.009","volume":"25","author":"Y Wu","year":"2017","unstructured":"Wu, Y., et al. (2017). Reciprocal regulation between the circadian clock and hypoxia signaling at the genome level in mammals. Cell Metabolism, 25, 73\u201385.","journal-title":"Cell Metabolism"},{"key":"10337_CR160","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cmet.2016.09.010","volume":"25","author":"CB Peek","year":"2017","unstructured":"Peek, C. B., et al. (2017). Circadian clock interaction with HIF1\u03b1 mediates oxygenic metabolism and anaerobic glycolysis in skeletal muscle. Cell Metabolism, 25, 86\u201392.","journal-title":"Cell Metabolism"},{"key":"10337_CR161","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","volume":"174","author":"ZE Walton","year":"2018","unstructured":"Walton, Z. E., et al. (2018). Acid suspends the circadian clock in hypoxia through inhibition of mTOR. Cell, 174, 72-87 e32.","journal-title":"Cell"},{"key":"10337_CR162","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cotox.2018.03.003","volume":"8","author":"Q Escalante-Covarrubias","year":"2018","unstructured":"Escalante-Covarrubias, Q., & Aguilar-Arnal, L. (2018). Environmental regulation of metabolism through the circadian clock. Current Opinion in Toxicology, 8, 93\u2013101.","journal-title":"Current Opinion in Toxicology"},{"key":"10337_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas, L. E., & Carnero, A. (2021). NAD(+) metabolism, stemness, the immune response, and cancer. Signal Transduction and Targeted Therapy, 6, Article 2.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10337_CR164","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243417","volume":"342","author":"CB Peek","year":"2013","unstructured":"Peek, C. B., et al. (2013). Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (New York, N.Y.), 342, Article 1243417.","journal-title":"Science (New York, N.Y.)"},{"key":"10337_CR165","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1126\/science.1170803","volume":"324","author":"Y Nakahata","year":"2009","unstructured":"Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009). Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science (New York, N.Y.), 324, 654\u2013657.","journal-title":"Science (New York, N.Y.)"},{"key":"10337_CR166","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1171641","volume":"324","author":"KM Ramsey","year":"2009","unstructured":"Ramsey, K. M., et al. (2009). Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science, 324, 651\u2013654.","journal-title":"Science"},{"key":"10337_CR167","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41388-023-02592-y","volume":"42","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y., Luo, Z., Gong, Y., Fu, Y., & Luo, Y. (2023). NAD(+) supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling. Oncogene, 42, 808\u2013824.","journal-title":"Oncogene"},{"key":"10337_CR168","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.dnarep.2014.08.006","volume":"23","author":"AF Santidrian","year":"2014","unstructured":"Santidrian, A. F., et al. (2014). Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer. DNA Repair, 23, 79\u201387.","journal-title":"DNA Repair"},{"key":"10337_CR169","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.7150\/jca.24275","volume":"9","author":"X Jin","year":"2018","unstructured":"Jin, X., et al. (2018). SIRT1 promotes formation of breast cancer through modulating Akt activity. Journal of Cancer, 9, 2012\u20132023.","journal-title":"Journal of Cancer"},{"key":"10337_CR170","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s42255-019-0136-6","volume":"1","author":"Z Liu","year":"2019","unstructured":"Liu, Z., et al. (2019). SIRT7 couples light-driven body temperature cues to hepatic circadian phase coherence and gluconeogenesis. Nature Metabolism, 1, 1141\u20131156.","journal-title":"Nature Metabolism"},{"key":"10337_CR171","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41419-023-05762-8","volume":"14","author":"K Xia","year":"2023","unstructured":"Xia, K., et al. (2023). Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer. Cell Death & Disease, 14, 250.","journal-title":"Cell Death & Disease"},{"key":"10337_CR172","doi-asserted-by":"crossref","unstructured":"Naik, A., & Decock, J. (2020). Lactate metabolism and immune modulation in breast cancer: A focused review on triple negative breast tumors. Frontiers in Oncology, 10,\u00a0598626.","DOI":"10.3389\/fonc.2020.598626"},{"key":"10337_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1292011","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu, M., et al. (2023). Circadian clock and lipid metabolism disorders: A potential therapeutic strategy for cancer. Frontiers in Endocrinology, 14, Article 1292011.","journal-title":"Frontiers in Endocrinology"},{"key":"10337_CR174","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. M. (2021). Lipid metabolism in cancer: New perspectives and emerging mechanisms. Developmental Cell, 56, 1363\u20131393.","journal-title":"Developmental Cell"},{"key":"10337_CR175","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12094-024-03554-w","volume":"27","author":"A Amaro-da-Cruz","year":"2025","unstructured":"Amaro-da-Cruz, A., Rubio-Tom\u00e1s, T., & \u00c1lvarez-Mercado, A. I. (2025). Specific microbiome patterns and their association with breast cancer: The intestinal microbiota as a potential biomarker and therapeutic strategy. Clinical and Translational Oncology, 27, 15\u201341.","journal-title":"Clinical and Translational Oncology"},{"key":"10337_CR176","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1038\/s41467-022-33609-x","volume":"13","author":"M Heddes","year":"2022","unstructured":"Heddes, M., et al. (2022). The intestinal clock drives the microbiome to maintain gastrointestinal homeostasis. Nature Communications, 13, 6068.","journal-title":"Nature Communications"},{"key":"10337_CR177","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019). The microbiome, cancer, and cancer therapy. Nature Medicine, 25, 377\u2013388.","journal-title":"Nature Medicine"},{"key":"10337_CR178","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10549-019-05407-5","volume":"178","author":"J Chen","year":"2019","unstructured":"Chen, J., et al. (2019). The microbiome and breast cancer: A review. Breast Cancer Research and Treatment, 178, 493\u2013496.","journal-title":"Breast Cancer Research and Treatment"},{"key":"10337_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1198259","volume":"13","author":"C Hoskinson","year":"2023","unstructured":"Hoskinson, C., Jiang, R. Y., & Stiemsma, L. T. (2023). Elucidating the roles of the mammary and gut microbiomes in breast cancer development. Frontiers in Oncology, 13, Article 1198259.","journal-title":"Frontiers in Oncology"},{"key":"10337_CR180","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D., et al. (2020). The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science, 368, 973\u2013980.","journal-title":"Science"},{"key":"10337_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14120683","author":"R Mir","year":"2024","unstructured":"Mir, R., et al. (2024). Emerging role of gut microbiota in breast cancer development and its implications in treatment. Metabolites. https:\/\/doi.org\/10.3390\/metabo14120683","journal-title":"Metabolites"},{"key":"10337_CR182","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/bs.irn.2016.07.002","volume":"131","author":"RM Voigt","year":"2016","unstructured":"Voigt, R. M., Forsyth, C. B., Green, S. J., Engen, P. A., & Keshavarzian, A. (2016). Circadian rhythm and the gut microbiome. International Review of Neurobiology, 131, 193\u2013205.","journal-title":"International Review of Neurobiology"},{"key":"10337_CR183","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13402-016-0281-9","volume":"39","author":"R Paduch","year":"2016","unstructured":"Paduch, R. (2016). The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cellular Oncology, 39, 397\u2013410.","journal-title":"Cellular Oncology"},{"key":"10337_CR184","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/cvr\/cvad057","volume":"119","author":"M Astone","year":"2023","unstructured":"Astone, M., Oberkersch, R. E., Tosi, G., Biscontin, A., & Santoro, M. M. (2023). The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis. Cardiovascular Research, 119, 1952\u20131968.","journal-title":"Cardiovascular Research"},{"key":"10337_CR185","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9, 265\u2013273.","journal-title":"Nature Reviews. Cancer"},{"key":"10337_CR186","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang, J., & Weinberg, R. A. (2008). Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Developmental Cell, 14, 818\u2013829.","journal-title":"Developmental Cell"},{"key":"10337_CR187","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1210\/me.2012-1071","volume":"26","author":"L Mao","year":"2012","unstructured":"Mao, L., et al. (2012). Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3beta. Molecular Endocrinology, 26, 1808\u20131820.","journal-title":"Molecular Endocrinology"},{"key":"10337_CR188","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12935-019-0902-2","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang, J., et al. (2019). Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression. Cancer Cell International, 19, 182.","journal-title":"Cancer Cell International"},{"key":"10337_CR189","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1073\/pnas.1222684110","volume":"110","author":"WW Hwang-Verslues","year":"2013","unstructured":"Hwang-Verslues, W. W., et al. (2013). Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proceedings of the National Academy of Sciences of the United States of America, 110, 12331\u201312336.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3545","volume":"4","author":"DQ Li","year":"2013","unstructured":"Li, D. Q., et al. (2013). Metastasis-associated protein 1 is an integral component of the circadian molecular machinery. Nature Communications, 4, Article 2545.","journal-title":"Nature Communications"},{"key":"10337_CR191","doi-asserted-by":"publisher","DOI":"10.5334\/jcr.203","volume":"19","author":"M Numata","year":"2021","unstructured":"Numata, M., et al. (2021). Metastasis of breast cancer promoted by circadian rhythm disruption due to light\/dark shift and its prevention by dietary quercetin in mice. Journal of Circadian Rhythms, 19, Article 2.","journal-title":"Journal of Circadian Rhythms"},{"key":"10337_CR192","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.4161\/15384101.2014.954454","volume":"13","author":"C Cadenas","year":"2014","unstructured":"Cadenas, C., et al. (2014). Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle, 13, 3282\u20133291.","journal-title":"Cell Cycle"},{"key":"10337_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006267","volume":"12","author":"NH Ha","year":"2016","unstructured":"Ha, N. H., Long, J., Cai, Q., Shu, X. O., & Hunter, K. W. (2016). The circadian rhythm gene Arntl2 is a metastasis susceptibility gene for estrogen receptor-negative breast cancer. PLoS Genetics, 12, Article e1006267.","journal-title":"PLoS Genetics"},{"key":"10337_CR194","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311854121","volume":"121","author":"S-Y Li","year":"2024","unstructured":"Li, S.-Y., et al. (2024). Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer. Proceedings of the National Academy of Sciences, 121, Article e2311854121.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10337_CR195","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-022-04875-y","volume":"607","author":"Z Diamantopoulou","year":"2022","unstructured":"Diamantopoulou, Z., et al. (2022). The metastatic spread of breast cancer accelerates during sleep. Nature, 607, 156\u2013162.","journal-title":"Nature"},{"key":"10337_CR196","doi-asserted-by":"publisher","first-page":"R432","DOI":"10.1016\/j.cub.2016.04.011","volume":"26","author":"T Roenneberg","year":"2016","unstructured":"Roenneberg, T., & Merrow, M. (2016). The circadian clock and human health. Current Biology, 26, R432-443.","journal-title":"Current Biology"},{"key":"10337_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.741295","volume":"12","author":"J Zhou","year":"2021","unstructured":"Zhou, J., Wang, J., Zhang, X., & Tang, Q. (2021). New insights into cancer chronotherapies. Frontiers in Pharmacology, 12, Article 741295.","journal-title":"Frontiers in Pharmacology"},{"key":"10337_CR198","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","volume":"53","author":"Y Lee","year":"2021","unstructured":"Lee, Y. (2021). Roles of circadian clocks in cancer pathogenesis and treatment. Experimental & Molecular Medicine, 53, 1529\u20131538.","journal-title":"Experimental & Molecular Medicine"},{"key":"10337_CR199","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.trecan.2023.11.002","volume":"10","author":"X Zhu","year":"2024","unstructured":"Zhu, X., Maier, G., & Panda, S. (2024). Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care. Trends in Cancer, 10, 196\u2013207.","journal-title":"Trends in Cancer"},{"key":"10337_CR200","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.tips.2018.07.003","volume":"39","author":"G Sulli","year":"2018","unstructured":"Sulli, G., Manoogian, E. N. C., Taub, P. R., & Panda, S. (2018). Training the circadian clock, clocking the drugs, and drugging the clock to prevent, manage, and treat chronic diseases. Trends in Pharmacological Sciences, 39, 812\u2013827.","journal-title":"Trends in Pharmacological Sciences"},{"key":"10337_CR201","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1038\/s41388-021-01778-6","volume":"40","author":"F Battaglin","year":"2021","unstructured":"Battaglin, F., et al. (2021). Clocking cancer: The circadian clock as a target in cancer therapy. Oncogene, 40, 3187\u20133200.","journal-title":"Oncogene"},{"key":"10337_CR202","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molmed.2010.07.005","volume":"16","author":"M Hatori","year":"2010","unstructured":"Hatori, M., & Panda, S. (2010). The emerging roles of melanopsin in behavioral adaptation to light. Trends in Molecular Medicine, 16, 435\u2013446.","journal-title":"Trends in Molecular Medicine"},{"key":"10337_CR203","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/07420528.2021.1992419","volume":"39","author":"HS Wu","year":"2022","unstructured":"Wu, H. S., Gao, F., Yan, L., & Given, C. (2022). Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep. Chronobiology International, 39, 221\u2013232.","journal-title":"Chronobiology International"},{"key":"10337_CR204","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.815872","volume":"16","author":"M Rissling","year":"2022","unstructured":"Rissling, M., et al. (2022). Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: A phase II randomized controlled trial. Frontiers in Neuroscience, 16, Article 815872.","journal-title":"Frontiers in Neuroscience"},{"key":"10337_CR205","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/endrev\/bnab027","volume":"43","author":"ENC Manoogian","year":"2022","unstructured":"Manoogian, E. N. C., Chow, L. S., Taub, P. R., Laferrere, B., & Panda, S. (2022). Time-restricted eating for the prevention and management of metabolic diseases. Endocrine Reviews, 43, 405\u2013436.","journal-title":"Endocrine Reviews"},{"key":"10337_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20743-7","volume":"12","author":"M Das","year":"2021","unstructured":"Das, M., et al. (2021). Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. Nature Communications, 12, Article 565.","journal-title":"Nature Communications"},{"key":"10337_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010324","author":"C Garcia-Chico","year":"2023","unstructured":"Garcia-Chico, C., et al. (2023). Physical exercise and the hallmarks of breast cancer: A narrative review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15010324","journal-title":"Cancers (Basel)"},{"key":"10337_CR208","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","volume":"18","author":"LS Chow","year":"2022","unstructured":"Chow, L. S., et al. (2022). Exerkines in health, resilience and disease. Nature Reviews Endocrinology, 18, 273\u2013289.","journal-title":"Nature Reviews. Endocrinology"},{"key":"10337_CR209","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz080","volume":"4","author":"CM Friedenreich","year":"2020","unstructured":"Friedenreich, C. M., Stone, C. R., Cheung, W. Y., & Hayes, S. C. (2020). Physical activity and mortality in cancer survivors: A systematic review and meta-analysis. JNCI Cancer Spectrum, 4, Article pkz080.","journal-title":"JNCI Cancer Spectrum"},{"key":"10337_CR210","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2017.09.015","volume":"27","author":"P Hojman","year":"2018","unstructured":"Hojman, P., Gehl, J., Christensen, J. F., & Pedersen, B. K. (2018). Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metabolism, 27, 10\u201321.","journal-title":"Cell Metabolism"},{"key":"10337_CR211","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd4100","volume":"13","author":"DJ Kojetin","year":"2014","unstructured":"Kojetin, D. J., & Burris, T. P. (2014). REV-ERB and ROR nuclear receptors as drug targets. Nature Reviews Drug Discovery, 13, 197\u2013216.","journal-title":"Nature Reviews Drug Discovery"},{"key":"10337_CR212","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0748730405277232","volume":"20","author":"F Guillaumond","year":"2005","unstructured":"Guillaumond, F., Dardente, H., Giguere, V., & Cermakian, N. (2005). Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. Journal of Biological Rhythms, 20, 391\u2013403.","journal-title":"Journal of Biological Rhythms"},{"key":"10337_CR213","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021174118","author":"X Cao","year":"2021","unstructured":"Cao, X., Yang, Y., Selby, C. P., Liu, Z., & Sancar, A. (2021). Molecular mechanism of the repressive phase of the mammalian circadian clock. Proceedings of the National Academy of Sciences of the United States of America. https:\/\/doi.org\/10.1073\/pnas.2021174118","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10337_CR214","doi-asserted-by":"publisher","unstructured":"Geldof, L., Deventer, K., Roels, K., Tudela, E., & Van Eeno, P. (2016). In vitro metabolic studies of REV-ERB agonists SR9009 and SR9011. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms17101676","DOI":"10.3390\/ijms17101676"},{"key":"10337_CR215","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature25170","volume":"553","author":"G Sulli","year":"2018","unstructured":"Sulli, G., et al. (2018). Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence. Nature, 553, 351\u2013355.","journal-title":"Nature"},{"key":"10337_CR216","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.1073\/pnas.1904226116","volume":"116","author":"P Dierickx","year":"2019","unstructured":"Dierickx, P., et al. (2019). SR9009 has REV-ERB\u2013independent effects on cell proliferation and metabolism. Proceedings of the National Academy of Sciences, 116, 12147\u201312152.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10337_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05392-6","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H., et al. (2022). SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXR\u03b1\/FOXM1 pathway independently of REV-ERBs. Cell Death & Disease, 13, Article 949.","journal-title":"Cell Death & Disease"},{"key":"10337_CR218","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ebiom.2016.02.028","volume":"6","author":"TG Oh","year":"2016","unstructured":"Oh, T. G., et al. (2016). The nuclear receptor, RORgamma, regulates pathways necessary for breast cancer metastasis. eBioMedicine, 6, 59\u201372.","journal-title":"eBioMedicine"},{"key":"10337_CR219","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/s41467-019-12529-3","volume":"10","author":"D Cai","year":"2019","unstructured":"Cai, D., et al. (2019). RORgamma is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nature Communications, 10, 4621.","journal-title":"Nature Communications"},{"key":"10337_CR220","doi-asserted-by":"publisher","first-page":"15755","DOI":"10.3390\/ijms131215755","volume":"13","author":"J Du","year":"2012","unstructured":"Du, J., & Xu, R. (2012). RORalpha, a potential tumor suppressor and therapeutic target of breast cancer. International Journal of Molecular Sciences, 13, 15755\u201315766.","journal-title":"International Journal of Molecular Sciences"},{"key":"10337_CR221","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1021\/cb100223d","volume":"5","author":"Y Wang","year":"2010","unstructured":"Wang, Y., et al. (2010). Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma. ACS Chemical Biology, 5, 1029\u20131034.","journal-title":"ACS Chemical Biology"},{"key":"10337_CR222","doi-asserted-by":"crossref","unstructured":"Rosenberg, L. H., et al. (2015). Therapeutic targeting of casein kinase 1delta in breast cancer. Science translational medicine, 7, 318ra202.","DOI":"10.1126\/scitranslmed.aac8773"},{"key":"10337_CR223","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","volume":"70","author":"A Siddiqui-Jain","year":"2010","unstructured":"Siddiqui-Jain, A., et al. (2010). CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Research, 70, 10288\u201310298.","journal-title":"Cancer Research"},{"key":"10337_CR224","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/neuonc\/noaf089","volume":"27","author":"P Chan","year":"2025","unstructured":"Chan, P., et al. (2025). Advancing clinical response against glioblastoma: Evaluating SHP1705 CRY2 activator efficacy in preclinical models and safety in phase I trials. Neuro-Oncology, 27, 1772\u20131786.","journal-title":"Neuro-Oncology"},{"key":"10337_CR225","doi-asserted-by":"publisher","DOI":"10.1101\/2024.04.26.590360","author":"Y Pan","year":"2024","unstructured":"Pan, Y., et al. (2024). Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancer. bioRxiv\u202f: The Preprint Server For Biology. https:\/\/doi.org\/10.1101\/2024.04.26.590360","journal-title":"bioRxiv : The Preprint Server For Biology"},{"key":"10337_CR226","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1389200223666220106124218","volume":"23","author":"D Lu","year":"2022","unstructured":"Lu, D., Wang, Z., & Wu, B. (2022). Pharmacokinetics-based chronotherapy. Current Drug Metabolism, 23, 2\u20137.","journal-title":"Current Drug Metabolism"},{"key":"10337_CR227","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.aax7621","volume":"365","author":"MD Ruben","year":"2019","unstructured":"Ruben, M. D., Smith, D. F., FitzGerald, G. A., & Hogenesch, J. B. (2019). Dosing time matters. Science (Washington, D.C.), 365, 547\u2013549.","journal-title":"Science (Washington, D.C.)"},{"key":"10337_CR228","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/07420528709083522","volume":"4","author":"B Lemmer","year":"1987","unstructured":"Lemmer, B., & Labrecque, G. (1987). Chronopharmacology and chronotherapeutics: Definitions and concepts. Chronobiology International, 4, 319\u2013329.","journal-title":"Chronobiology International"},{"key":"10337_CR229","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pharmthera.2019.05.018","volume":"202","author":"S Ohdo","year":"2019","unstructured":"Ohdo, S., Koyanagi, S., & Matsunaga, N. (2019). Chronopharmacological strategies focused on chrono-drug discovery. Pharmacology & Therapeutics, 202, 72\u201390.","journal-title":"Pharmacology & Therapeutics"},{"key":"10337_CR230","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2016.03.004","volume":"22","author":"R Dallmann","year":"2016","unstructured":"Dallmann, R., Okyar, A., & Levi, F. (2016). Dosing-time makes the poison: Circadian regulation and pharmacotherapy. Trends in Molecular Medicine, 22, 430\u2013445.","journal-title":"Trends in Molecular Medicine"},{"key":"10337_CR231","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12672-024-01643-4","volume":"15","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani, M., et al. (2024). Circadian rhythms and cancer: Implications for timing in therapy. Discovery Oncology, 15, 767.","journal-title":"Discovery Oncology"},{"key":"10337_CR232","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clon.2018.10.001","volume":"31","author":"K Johnson","year":"2019","unstructured":"Johnson, K., et al. (2019). Genetic variants predict optimal timing of radiotherapy to reduce side-effects in breast cancer patients. Clinical Oncology (Royal College of Radiologists (Great Britain)), 31, 9\u201316.","journal-title":"Clinical Oncology (Royal College of Radiologists (Great Britain))"},{"key":"10337_CR233","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jrr\/rrt141","volume":"55","author":"JM Noh","year":"2014","unstructured":"Noh, J. M., et al. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Journal of Radiation Research, 55, 553\u2013558.","journal-title":"Journal of Radiation Research"},{"key":"10337_CR234","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.687672","volume":"11","author":"L Bermudez-Guzman","year":"2021","unstructured":"Bermudez-Guzman, L., Blanco-Saborio, A., Ramirez-Zamora, J., & Lovo, E. (2021). The time for chronotherapy in radiation oncology. Frontiers in Oncology, 11, Article 687672.","journal-title":"Frontiers in Oncology"},{"key":"10337_CR235","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G., & Winer, E. P. (2019). Breast cancer treatment: A review. JAMA\u202f: The Journal of the American Medical Association, 321, 288\u2013300.","journal-title":"JAMA : The Journal of the American Medical Association"},{"key":"10337_CR236","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/curroncol28040229","volume":"28","author":"AA Beltran-Bless","year":"2021","unstructured":"Beltran-Bless, A. A., et al. (2021). Does the time of day at which endocrine therapy is taken affect breast cancer patient outcomes? Current Oncology, 28, 2523\u20132528.","journal-title":"Current Oncology"},{"key":"10337_CR237","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-015-3452-x","volume":"152","author":"L Binkhorst","year":"2015","unstructured":"Binkhorst, L., et al. (2015). Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients. Breast Cancer Research and Treatment, 152, 119\u2013128.","journal-title":"Breast Cancer Research and Treatment"},{"key":"10337_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105141","volume":"104","author":"S Giacchetti","year":"2024","unstructured":"Giacchetti, S., et al. (2024). Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: Results of a sub-study of the UCBG- UNIRAD trial. eBioMedicine, 104, Article 105141.","journal-title":"eBioMedicine"},{"key":"10337_CR239","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41523-025-00762-7","volume":"11","author":"MF Savard","year":"2025","unstructured":"Savard, M. F., et al. (2025). A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study). NPJ Breast Cancer, 11, 49.","journal-title":"NPJ Breast Cancer"},{"key":"10337_CR240","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","volume":"24","author":"S Paul","year":"2024","unstructured":"Paul, S., et al. (2024). Cancer therapy with antibodies. Nature Reviews. Cancer, 24, 399\u2013426.","journal-title":"Nature Reviews. Cancer"},{"key":"10337_CR241","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010644","author":"BC Ozdemir","year":"2025","unstructured":"Ozdemir, B. C., et al. (2025). Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trials. Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010644","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10337_CR242","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41416-024-02704-9","volume":"131","author":"A Karaboue","year":"2024","unstructured":"Karaboue, A., et al. (2024). Why does circadian timing of administration matter for immune checkpoint inhibitors\u2019 efficacy? British Journal of Cancer, 131, 783\u2013796.","journal-title":"British Journal of Cancer"},{"key":"10337_CR243","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S1470-2045(21)00546-5","volume":"22","author":"DC Qian","year":"2021","unstructured":"Qian, D. C., et al. (2021). Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): A propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncology, 22, 1777\u20131786.","journal-title":"Lancet Oncology"},{"key":"10337_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205071","author":"A Amiama-Roig","year":"2022","unstructured":"Amiama-Roig, A., Verdugo-Sivianes, E. M., Carnero, A., & Blanco, J. R. (2022). Chronotherapy: Circadian rhythms and their influence in cancer therapy. Cancers. https:\/\/doi.org\/10.3390\/cancers14205071","journal-title":"Cancers"},{"key":"10337_CR245","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand, U., et al. (2023). Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases, 10, 1367\u20131401.","journal-title":"Genes & Diseases"},{"key":"10337_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.960317","volume":"12","author":"CM Tilsed","year":"2022","unstructured":"Tilsed, C. M., Fisher, S. A., Nowak, A. K., Lake, R. A., & Lesterhuis, W. J. (2022). Cancer chemotherapy: Insights into cellular and tumor microenvironmental mechanisms of action. Frontiers in Oncology, 12, Article 960317.","journal-title":"Frontiers in Oncology"},{"key":"10337_CR247","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1535-7163.MCT-06-0177","volume":"5","author":"PA Wood","year":"2006","unstructured":"Wood, P. A., Du-Quiton, J., You, S., & Hrushesky, W. J. (2006). Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Molecular Cancer Therapeutics, 5, 2023\u20132033.","journal-title":"Molecular Cancer Therapeutics"},{"key":"10337_CR248","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/bcp.13007","volume":"82","author":"BA Jacobs","year":"2016","unstructured":"Jacobs, B. A., et al. (2016). Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers. British Journal of Clinical Pharmacology, 82, 706\u2013716.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10337_CR249","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/07420520500179969","volume":"22","author":"ZL Zeng","year":"2005","unstructured":"Zeng, Z. L., et al. (2005). Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients. Chronobiology International, 22, 741\u2013754.","journal-title":"Chronobiology International"},{"key":"10337_CR250","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.1016\/S0959-8049(01)81635-X","volume":"37","author":"S Giacchetti","year":"2001","unstructured":"Giacchetti, S., et al. (2001). Chronomodulated (Chrono) irinotecan (CPT) versus standard (STD) infusion in patients (pts) with metastatic colorectal cancer (MCC), a randomized multicenter trial. European Journal of Cancer, 37, S309.","journal-title":"European Journal of Cancer"},{"key":"10337_CR251","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/JCO.1990.8.4.705","volume":"8","author":"F Levi","year":"1990","unstructured":"Levi, F., et al. (1990). Chemotherapy of advanced ovarian cancer with 4\u2019-O-tetrahydropyranyl doxorubicin and cisplatin: A randomized phase II trial with an evaluation of circadian timing and dose-intensity. Journal of Clinical Oncology\u202f: Official Journal of the American Society of Clinical Oncology, 8, 705\u2013714.","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"10337_CR252","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.21873\/anticanres.17691","volume":"45","author":"Y Seto","year":"2025","unstructured":"Seto, Y., Miyamoto, K., Inoue, D., Okazaki, F., & To, H. (2025). Dosing time-dependent effects of paclitaxel on peripheral neuropathy in mice. Anticancer Research, 45, 3305\u20133314.","journal-title":"Anticancer Research"},{"key":"10337_CR253","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1158\/1078-0432.CCR-13-0171","volume":"20","author":"ZL Zeng","year":"2014","unstructured":"Zeng, Z. L., et al. (2014). Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clinical Cancer Research\u202f: An Official Journal of the American Association for Cancer Research, 20, 1042\u20131052.","journal-title":"Clinical Cancer Research : An Official Journal of the American Association for Cancer Research"},{"key":"10337_CR254","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900667","volume":"6","author":"Q Tang","year":"2019","unstructured":"Tang, Q., et al. (2019). Periodic oxaliplatin administration in synergy with PER2-mediated PCNA transcription repression promotes chronochemotherapeutic efficacy of OSCC. Advanced Science, 6, Article 1900667.","journal-title":"Advanced Science"},{"key":"10337_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119597","volume":"278","author":"RJ Reiter","year":"2021","unstructured":"Reiter, R. J., et al. (2021). Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sciences (Oxford, England), 278, Article 119597.","journal-title":"Life Sciences (Oxford, England)"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10337-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:03:11Z","timestamp":1778220191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":255,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["10337"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10337-y","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"31"}}